Vincent C Marconi Selected Research

lenzilumab

1/2023	C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 'LIVE-AIR' trial.
1/2022	Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.
5/2021	LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincent C Marconi Research Topics

Disease

23	COVID-19 02/2024 - 05/2020
20	Acquired Immunodeficiency Syndrome (AIDS) 07/2023 - 01/2008
17	Infections 01/2023 - 07/2008
10	HIV Infections (HIV Infection) 01/2024 - 09/2008
10	Inflammation (Inflammations) 09/2023 - 07/2008
8	Disease Progression 01/2024 - 01/2008
8	Tuberculosis (Tuberculoses) 05/2023 - 01/2012
6	Viremia 12/2021 - 07/2015
5	Neoplasms (Cancer) 04/2024 - 08/2008
4	Cardiovascular Diseases (Cardiovascular Disease) 09/2023 - 06/2008
3	Weight Gain 03/2024 - 10/2021
3	Obesity 07/2023 - 01/2017
3	Pneumonia (Pneumonitis) 01/2022 - 05/2009
3	Pain (Aches) 01/2020 - 01/2020
3	Chronic Pain 01/2020 - 01/2020
2	Carcinogenesis 03/2024 - 03/2023
2	Smallpox (Variola) 09/2023 - 01/2023
2	Chronic Disease (Chronic Diseases) 09/2023 - 02/2010
2	Malaria 05/2023 - 09/2009
2	Pulmonary Tuberculosis 02/2023 - 01/2022
2	Hepatitis C 01/2023 - 01/2019
2	Critical Illness (Critically Ill) 01/2022 - 08/2015
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 01/2019
2	Communicable Diseases (Infectious Diseases) 01/2015 - 06/2008
2	Virus Diseases (Viral Diseases) 04/2011 - 12/2010
2	HIV Seropositivity 01/2011 - 09/2008
1	Cognitive Dysfunction 05/2024
1	Post-Acute COVID-19 Syndrome 11/2023
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 11/2023
1	Weight Loss (Weight Reduction) 07/2023
1	HIV Wasting Syndrome 07/2023
1	Coinfection 06/2023
1	Heart Diseases (Heart Disease) 01/2023

Drug/Important Bio-Agent (IBA)

10	RNA (Ribonucleic Acid)IBA 01/2023 - 12/2009
8	Biomarkers (Surrogate Marker)IBA 04/2024 - 09/2008
8	baricitinibIBA 02/2024 - 01/2021
7	VaccinesIBA 01/2023 - 01/2008
6	remdesivirIBA 02/2024 - 01/2021
5	Oxygen (Dioxygen)IBA 01/2023 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2010
4	Lipopolysaccharide ReceptorsIBA 01/2022 - 01/2017
4	CytokinesIBA 12/2021 - 01/2021
4	ChemokinesIBA 05/2021 - 01/2008
3	Integrase InhibitorsIBA 03/2024 - 10/2021
3	Antiviral Agents (Antivirals)IBA 02/2024 - 11/2018
3	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2024 - 01/2023
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 05/2021
3	ruxolitinibIBA 01/2023 - 12/2021
3	lenzilumabIBA 01/2023 - 05/2021
3	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 12/2021
3	fibrin fragment D (D-dimer)IBA 05/2021 - 01/2017
2	InterferonsIBA 03/2024 - 03/2023
2	Immunologic Factors (Immunomodulators)IBA 02/2024 - 01/2022
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 12/2023 - 01/2023
2	LipidsIBA 07/2023 - 06/2008
2	Tenofovir (Viread)FDA Link 01/2023 - 08/2012
2	Monoclonal AntibodiesIBA 01/2023 - 01/2022
2	COVID-19 VaccinesIBA 10/2022 - 12/2021
2	mRNA VaccinesIBA 01/2022 - 09/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 05/2021
2	Janus Kinase InhibitorsIBA 01/2022 - 01/2019
2	Janus Kinase 1IBA 01/2022 - 12/2021
2	Immunoglobulin G (IgG)IBA 12/2021 - 05/2020
2	efavirenz (Sustiva)FDA Link 12/2021 - 10/2021
2	dolutegravirIBA 10/2021 - 03/2019
2	Cocaine (Cocaine HCl)IBA 01/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2017
2	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2020
2	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 01/2020
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2013 - 01/2012
2	Ritonavir (Norvir)FDA Link 01/2013 - 01/2012
2	Lopinavir FDA Link 01/2013 - 01/2012
2	Antigen Receptors (Antigen Receptor)IBA 09/2009 - 07/2008
1	DNA (Deoxyribonucleic Acid)IBA 05/2024
1	tecovirimatIBA 01/2024
1	sotrovimabIBA 12/2023
1	Naltrexone (ReVia)FDA LinkGeneric 11/2023
1	ProteomeIBA 09/2023
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 07/2023
1	Glucose (Dextrose)FDA LinkGeneric 07/2023
1	Chemokine ReceptorsIBA 06/2023
1	Guanosine Diphosphate (GDP)IBA 05/2023
1	erucylphosphocholineIBA 04/2023
1	hydrogen sulfite (bisulfite)IBA 03/2023
1	tixagevimabIBA 01/2023
1	cilgavimabIBA 01/2023
1	CreatinineIBA 01/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	C-Reactive ProteinIBA 01/2023

Therapy/Procedure

24	Therapeutics 07/2023 - 08/2008
12	Highly Active Antiretroviral Therapy (HAART) 10/2021 - 08/2008
10	Art Therapy 09/2023 - 08/2012
8	Artificial Respiration (Mechanical Ventilation) 01/2023 - 08/2015
3	Ambulatory Care (Outpatient Care) 12/2023 - 12/2016
3	Physical Therapy Modalities (Physical Therapy Technique) 01/2020 - 01/2020
2	Precision Medicine 11/2023 - 01/2023
2	Noninvasive Ventilation 01/2022 - 01/2021
2	Musculoskeletal Manipulations (Manipulative Therapy) 01/2020 - 01/2020
1	Palliative Care (Palliative Therapy) 04/2023